Literature DB >> 6184608

Human U1 and U2 small nuclear ribonucleoproteins contain common and unique polypeptides.

C S Kinlaw, S K Dusing-Swartz, S M Berget.   

Abstract

Immunoprecipitation of human small nuclear ribonucleoproteins (snRNPs) containing the small nuclear RNAs U1, U2, U4, U5, and U6 with two antibodies produced in certain patients suffering from systemic lupus erythematosus was used to identify the polypeptides present on human U1 and U2 snRNPs. U1 and U2 snRNPs contain both common and unique polypeptides; visualization of the differences was possible through the use of non-methionine protein labeling and partial fractionation of snRNP populations. To facilitate comparisons with results from other laboratories, we have designated the snRNP polypeptides by their molecular weights. Four small polypeptides, P8, P9, P10, and P12, of 8,000 to 12,000 daltons, are each present in equal amounts on both U1 and U2 snRNPs. U1 snRNPs also contain a unique 30,000-dalton polypeptide, P30, whereas U2 snRNPs contain a unique 27,000-dalton, methionine-deficient polypeptide, P27. A closely migrating pair of polypeptides, P23 and P22, of 23,000 and 21,500 daltons, respectively, is present on both snRNPs; U2 snRNPs are enriched in the former, and U1 snRNPs are enriched in the latter.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184608      PMCID: PMC369914          DOI: 10.1128/mcb.2.10.1159-1166.1982

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  15 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Nuclear ribonucleoprotein complexes containing U1 and U2 RNA.

Authors:  N B Raj; T S Ro-Choi; H Busch
Journal:  Biochemistry       Date:  1975-10-07       Impact factor: 3.162

3.  Nuclear ribonucleoproteins recognized by human antinuclear antibodies in retrovirus-infected cells.

Authors:  J P Barque; P Yeni; L Peraudeau; F Danon; C J Larsen
Journal:  Biochem Biophys Res Commun       Date:  1981-03-16       Impact factor: 3.575

4.  Small nuclear RNA molecules in nuclear ribonucleoprotein complexes from mouse erythroleukemia cells.

Authors:  E F Howard
Journal:  Biochemistry       Date:  1978-08-08       Impact factor: 3.162

5.  A mechanism for RNA splicing.

Authors:  J Rogers; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

6.  A small nuclear ribonucleoprotein is required for splicing of adenoviral early RNA sequences.

Authors:  V W Yang; M R Lerner; J A Steitz; S J Flint
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

7.  Isolation and characterization of nuclear ribonucleoprotein complexes using human anti-nuclear ribonucleoprotein antibodies.

Authors:  A S Douvas; W E Stumph; P Reyes; E M Tan
Journal:  J Biol Chem       Date:  1979-05-10       Impact factor: 5.157

8.  Are snRNPs involved in splicing?

Authors:  M R Lerner; J A Boyle; S M Mount; S L Wolin; J A Steitz
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

9.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

10.  Purification and biochemical characterization of nuclear ribonucleoprotein antigen using purified antibody from serum of a patient with mixed connective tissue disease.

Authors:  M Takano; P F Agris; G C Sharp
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more
  19 in total

1.  20S small nuclear ribonucleoprotein U5 shows a surprisingly complex protein composition.

Authors:  M Bach; G Winkelmann; R Lührmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes.

Authors:  J Craft; T Mimori; T L Olsen; J A Hardin
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

3.  Molecular cloning of the cDNA for the human U2 snRNA-specific A' protein.

Authors:  P T Sillekens; R P Beijer; W J Habets; W J van Verooij
Journal:  Nucleic Acids Res       Date:  1989-03-11       Impact factor: 16.971

4.  Reversible chemical cross-linking and ribonuclease digestion analysis of the organization of proteins in ribonucleoprotein particles.

Authors:  S G Harris; T E Martin; H C Smith
Journal:  Mol Cell Biochem       Date:  1988-11       Impact factor: 3.396

5.  The Mr 70,000 protein of the U1 small nuclear ribonucleoprotein particle binds to the 5' stem-loop of U1 RNA and interacts with Sm domain proteins.

Authors:  J R Patton; T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

6.  Protein binding sites are conserved in U1 small nuclear RNA from insects and mammals.

Authors:  E D Wieben; S J Madore; T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Rapid inhibition of processing and assembly of small nuclear ribonucleoproteins after infection with vesicular stomatitis virus.

Authors:  L D Fresco; M G Kurilla; J D Keene
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

8.  Characterization of a phosphoprotein associated with the SS-B/La nuclear antigen in adenovirus-infected and uninfected KB cells.

Authors:  L I Pizer; J S Deng; R M Stenberg; E M Tan
Journal:  Mol Cell Biol       Date:  1983-07       Impact factor: 4.272

9.  Polypeptide components of human small nuclear ribonucleoproteins.

Authors:  J C Wooley; L R Zukerberg; S Y Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  Distribution of snRNP complexes in rat liver nuclear extracts: biochemical and immunochemical analysis.

Authors:  A Guialis; A Dangli; C E Sekeris
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.